MENU
CTOR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Citius Oncology (CTOR) Ownership - Who owns Citius Oncology?
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products... Show more
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
141.85M
P/E Ratio
N/A
Total Cash
112
Projected Growth
N/A
Total Debt
3.8M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CTOR
Capitalization
142M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
112
Total Cash/Share
0.00
Total Debt
3.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
35.6M
P/B Ratio
3.98
Cash Flow
N/A
Earnings
-0.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.16K
Current Ratio
0.36
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-25.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.41
Shares Held By Institutions
346K
Shares Outstanding - Current
78.4M
Total Liabilities
55.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
57.391
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information